A May 2024 cohort study reveals prenatal PFAS exposure reduces maternal beta cell function by 15-20%, increasing diabetes risk. EU proposals and NIH funding highlight urgent public health responses. R...
June 2024 research demonstrates prenatal PFAS exposure disrupts pancreatic beta cell function, increasing diabetes risk. EFSA slashes safety limits by 80% as EWG urges pregnancy precautions. Emerging ...
New research reveals prenatal PFAS exposure disrupts maternal beta cell function, increasing diabetes risk, with significant socioeconomic disparities in exposure levels. Recent studies show prenatal ...
NIH-funded research shows prenatal PFAS exposure increases maternal beta-cell dysfunction risk by 15-20% a decade postpartum, with epigenetic changes as a key mechanism. Emerging evidence connects pre...
Recent research shows prenatal PFAS exposure disrupts maternal beta cell function, increasing diabetes risk years after pregnancy, with significant public health implications. Groundbreaking study rev...
New research reveals prenatal PFAS exposure may impair maternal beta cell function long-term, increasing diabetes risk amid widespread contamination concerns. Groundbreaking study connects prenatal PF...
Emerging research shows prenatal PFAS exposure significantly impacts maternal metabolic health, increasing risks of gestational diabetes and long-term beta cell dysfunction. Groundbreaking studies dem...
Recent research shows prenatal PFAS exposure significantly increases risks of gestational diabetes and insulin resistance, with new data revealing widespread contamination in pregnant women. Emerging ...
New research shows prenatal PFAS exposure disrupts maternal beta-cell function for 7-9 years postpartum, with significant implications for metabolic health and policy. Groundbreaking study reveals per...
Recent studies reveal that prenatal PFAS exposure is associated with impaired maternal beta cell function, increasing risks for gestational diabetes and metabolic disorders. New research highlights th...
